Upadhyay D, Nogales J, Mokariya J, Vala R, Tandon V, Banerjee S
RSC Adv. 2024; 14(37):27174-27186.
PMID: 39193280
PMC: 11348845.
DOI: 10.1039/d4ra04171b.
Palaniyappan S, Sridhar A, Arumugam M, Ramasamy T
Appl Biochem Biotechnol. 2023; 196(2):729-773.
PMID: 37184725
DOI: 10.1007/s12010-023-04565-z.
Damale M, Patil R, Ansari S, Alkahtani H, Almehizia A, Shinde D
RSC Adv. 2022; 9(45):26176-26208.
PMID: 35531003
PMC: 9070323.
DOI: 10.1039/c9ra03281a.
Gong W, Li Y, Xian J, Yang L, Wang Y, Zhang X
Cancer Cell Int. 2022; 22(1):181.
PMID: 35524253
PMC: 9074231.
DOI: 10.1186/s12935-022-02592-0.
Hagras M, Mandour A, Mohamed E, Elkaeed E, Gobaara I, Mehany A
RSC Adv. 2022; 11(63):39728-39741.
PMID: 35494162
PMC: 9044549.
DOI: 10.1039/d1ra07922k.
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.
Moutabian H, Majdaeen M, Ghahramani-Asl R, Yadollahi M, Gharepapagh E, Ataei G
Cancer Cell Int. 2022; 22(1):142.
PMID: 35366874
PMC: 8976963.
DOI: 10.1186/s12935-022-02561-7.
LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis.
Li P, Zeng Y, Chen Y, Huang P, Chen X, Zheng W
Cancer Cell Int. 2022; 22(1):116.
PMID: 35279146
PMC: 8917722.
DOI: 10.1186/s12935-022-02536-8.
Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma.
Liu W, Zheng L, Zhang R, Hou P, Wang J, Wu L
Mol Cancer. 2022; 21(1):72.
PMID: 35277182
PMC: 8915544.
DOI: 10.1186/s12943-022-01529-5.
Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis.
Wen W, Xu D, Piao Y, Li X
Cancer Cell Int. 2022; 22(1):60.
PMID: 35114996
PMC: 8811994.
DOI: 10.1186/s12935-022-02482-5.
Patient-derived xenograft models in hepatopancreatobiliary cancer.
Pan B, Wei X, Xu X
Cancer Cell Int. 2022; 22(1):41.
PMID: 35090441
PMC: 8796540.
DOI: 10.1186/s12935-022-02454-9.
MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system.
Zhou X, Wang H, Li D, Song N, Yang F, Xu W
J Cell Mol Med. 2022; 26(5):1621-1628.
PMID: 35088536
PMC: 8899195.
DOI: 10.1111/jcmm.17203.
New Insights Into Cancer Chronotherapies.
Zhou J, Wang J, Zhang X, Tang Q
Front Pharmacol. 2021; 12:741295.
PMID: 34966277
PMC: 8710512.
DOI: 10.3389/fphar.2021.741295.
Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway.
Yang P, Chen W, Xu H, Yang J, Jiang J, Jiang Y
Cancer Cell Int. 2021; 21(1):635.
PMID: 34844613
PMC: 8628426.
DOI: 10.1186/s12935-021-02350-8.
Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis.
He Y, Chen J, Peng X, Xia Y, Su Y
Cancer Cell Int. 2021; 21(1):626.
PMID: 34838022
PMC: 8627083.
DOI: 10.1186/s12935-021-02329-5.
Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis.
Liu R, Wan Q, Zhao R, Xiao H, Cen Y, Xu X
Cancer Cell Int. 2021; 21(1):614.
PMID: 34809619
PMC: 8607648.
DOI: 10.1186/s12935-021-02325-9.
RNA m6A methylation regulators in ovarian cancer.
Guo J, Zheng J, Zhang H, Tong J
Cancer Cell Int. 2021; 21(1):609.
PMID: 34794452
PMC: 8600856.
DOI: 10.1186/s12935-021-02318-8.
Chitosan as possible inhibitory agents and delivery systems in leukemia.
Zivarpour P, Hallajzadeh J, Asemi Z, Sadoughi F, Sharifi M
Cancer Cell Int. 2021; 21(1):544.
PMID: 34663339
PMC: 8524827.
DOI: 10.1186/s12935-021-02243-w.
Synthesis of Michael Adducts as Key Building Blocks for Potential Analgesic Drugs: In vitro, in vivo and in silico Explorations.
Ahmad S, Mahnashi M, Alyami B, Alqahtani Y, Ullah F, Ayaz M
Drug Des Devel Ther. 2021; 15:1299-1313.
PMID: 33790541
PMC: 8001115.
DOI: 10.2147/DDDT.S292826.
Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.
Machado Marinho E, de Andrade Neto J, Silva J, da Silva C, Cavalcanti B, Marinho E
Microb Pathog. 2020; 148:104365.
PMID: 32619669
PMC: 7834391.
DOI: 10.1016/j.micpath.2020.104365.
Evaluation of anti-tumour properties of two depsidones - Unguinol and Aspergillusidone D - in triple-negative MDA-MB-231 breast tumour cells.
Zwartsen A, Chottanapund S, Kittakoop P, Navasumrit P, Ruchirawat M, van Duursen M
Toxicol Rep. 2019; 6:1216-1222.
PMID: 31788435
PMC: 6880138.
DOI: 10.1016/j.toxrep.2019.10.012.